0000874015-13-000103.txt : 20130923 0000874015-13-000103.hdr.sgml : 20130923 20130923193649 ACCESSION NUMBER: 0000874015-13-000103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130919 FILED AS OF DATE: 20130923 DATE AS OF CHANGE: 20130923 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENNETT C FRANK CENTRAL INDEX KEY: 0001073387 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 131110947 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-09-19 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001073387 BENNETT C FRANK C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 SVP, Antisense Research Common Stock 2013-09-19 2013-09-19 4 M 0 10000 15.38 A 12866 D Common Stock 2013-09-19 2013-09-19 4 S 0 10000 35.02 D 2866 D Employee Stock Option (right to buy) 15.38 2013-09-19 2013-09-19 4 M 0 10000 0 D 2012-01-02 2015-01-01 Common Stock 10000 26200 D Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 8/12/2013. /s/B. Lynne Parshall, attorney-in-fact 2013-09-23